US2008133008A1PendingUtilityA1

Cartilage repair mixture containing allograft chondrocytes

Assignee: MUSCUOSKELETAL TRANSPLANT FOUNPriority: Apr 29, 2003Filed: Jan 31, 2008Published: Jun 5, 2008
Est. expiryApr 29, 2023(expired)· nominal 20-yr term from priority
A61F 2002/2835A61L 27/3852A61L 27/3817A61K 35/32A61K 35/28A61L 27/56A61B 17/00491A61L 27/20A61F 2310/00365A61F 2002/30759A61L 27/3612A61L 2430/06A61L 27/3834A61L 27/24A61F 2002/30764A61L 27/58A61K 38/28A61F 2002/30062A61F 2/30744A61F 2230/0069A61L 27/3683A61F 2/3859A61F 2/3094A61F 2310/00383A61L 27/3821A61F 2002/2817A61K 38/18A61F 2210/0004A61F 2002/30224A61F 2002/30225A61L 27/48A61F 2/28A61L 27/3654A61F 2/30756
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention is directed toward a sterile cartilage defect implant material comprising milled lyophilized allograft cartilage pieces ranging from 0.01 mm to 1.0 mm in size in a bioabsorbable carrier taken from a group consisting of sodium hyaluronate, hyaluronic acid and its derivatives, gelatin, collagen, chitosan, alginate, buffered PBS, Dextran or mixed polymers with allograft chondrocytes added in an amount ranging from 2.5×10 5 to 2.5×10 7 .

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . (canceled) 
     
     
         7 . (canceled) 
     
     
         8 . (canceled) 
     
     
         9 . (canceled) 
     
     
         10 . (canceled) 
     
     
         11 . (canceled) 
     
     
         12 . (canceled) 
     
     
         13 . (canceled) 
     
     
         14 . (canceled) 
     
     
         15 . (canceled) 
     
     
         16 . (canceled) 
     
     
         17 . (canceled) 
     
     
         18 . A method of placing a cartilage defect material in a cartilage defect, said material comprising allograft articular cartilage which has been lyophilized and mixed in a bioabsorbable carrier comprising the steps of:
 (a) cutting patient tissue at a site of a cartilage defect to remove the diseased area of cartilage;   (b) placing a mixture of milled allograft cartilage in a bioabsorbable carrier in the area where cartilage has been removed;   (c) adding allograft chondrocytes taken from a human donor having an age ranging from about 3 months to about 20 years to said mixture of milled allograft cartilage in a bioabsorbable carrier;   (d) sealing a cover with a biological glue over the mixture of milled allograft cartilage in a bioabsorbable carrier and added allograft chondrocytes to contain the mixture in cartilage defect site for a predetermined period of time to allow the formation of cartilage.   
     
     
         19 . A sterile cartilage defect material as claimed in  claim 18  wherein said milled cartilage pieces have been lyophilized to have a water content ranging from about 0.1% to about 8.0%. 
     
     
         20 . A sterile cartilage repair material as claimed in  claim 18  wherein said allograft chondrocytes are expanded growth chondrocytes added in amount ranging from 2.5×10 5  to about 2.5×10 7 .

Join the waitlist — get patent alerts

Track US2008133008A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.